Estrella Immunopharma

(NASDAQ) ESLA

Current Price$1.27

Market Cap$53.76M

Since IPO (2021)-87%

5 YearN/A

1 Year+9%

1 Month-34%

Estrella Immunopharma Financials at a Glance

Market Cap

$53.76M

Revenue (TTM)

$0.00

Net Income (TTM)

$13.06M

EPS (TTM)

$-0.36

P/E Ratio

-3.53

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.27

Volume

16,377.059

Open

$1.26

Price

$1.27

Volume

16,377.059

Open

$1.26

Previous Close

$1.26

Daily Range

$1.22 - $1.28

52-Week Range

$0.78 - $3.15

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.27

Volume

16,377.059

Open

$1.26

Previous Close

$1.26

Daily Range

$1.22 - $1.28

52-Week Range

$0.78 - $3.15

ESLA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Estrella Immunopharma

Industry

Biotechnology

Sector

Health Care

CEO

Cheng Liu, PhD

Website

www.estrellabio.com

Headquarters

EmeryVille, CA 94608, US

ESLA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-315%

Return on Capital

Return on Assets

-4%

Earnings Yield

-28.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$53.76M

Shares Outstanding

42.67M

Volume

16.38K

Avg. Volume

95.44K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$13.06M

EBITDA

$13.06M

Operating Cash Flow

$1.79M

Capital Expenditure

$0.00

Free Cash Flow

$1.79M

Cash & ST Invst.

$1.38M

Total Debt

$0.00

Estrella Immunopharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$53.76M

N/A

Market Cap/Employee

$17.92M

N/A

Employees

N/A

Net Income

$613.17K

+41.6%

EBITDA

$613.20K

+41.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$1.38M

+51.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-4.11%

N/A

Return on Invested Capital

1.26%

N/A

Free Cash Flow

$177.49K

+80.2%

Operating Cash Flow

$177.49K

+80.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TILInstil Bio, Inc.

TILInstil Bio, Inc.$8.07-1.16%

ATOSAtossa Therapeutics, Inc.

ATOSAtossa Therapeutics, Inc.$5.55-0.89%

TVGNTevogen Bio Holdings Inc.

TVGNTevogen Bio Holdings Inc.$7.08-5.41%

EXOZeXoZymes, Inc.

EXOZeXoZymes, Inc.$9.80+1.87%

ANEBAnebulo Pharmaceuticals, Inc.

ANEBAnebulo Pharmaceuticals, Inc.$0.46-12.00%

ONCYOncolytics Biotech Inc.

ONCYOncolytics Biotech Inc.$0.90+1.53%

TLSATiziana Life Sciences Ltd

TLSATiziana Life Sciences Ltd$1.55-1.90%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.38-0.00%

TSDDGraniteShares ETF Trust - GraniteShares 2x Short Tsla Daily ETF

TSDDGraniteShares ETF Trust - GraniteShares 2x Short Tsla Daily ETF$6.82-0.09%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$17.06+0.09%

NOKNokia

NOKNokia$13.94+0.09%

NVDANvidia

NVDANvidia$219.79+0.02%

INTCIntel

INTCIntel$127.93+0.02%

TSLATesla

TSLATesla$447.49+0.04%

Questions About ESLA

What is the current price of Estrella Immunopharma?

Estrella Immunopharma is trading at $1.28 per share.

What is the 52-week range for Estrella Immunopharma?

Over the past 52 weeks, Estrella Immunopharma has traded between $0.78 and $3.15.

How much debt does Estrella Immunopharma have?

As of the most recent reporting period, Estrella Immunopharma reported total debt of N/A.

How much cash does Estrella Immunopharma have on hand?

Estrella Immunopharma reported $1.38M in cash and cash equivalents in its most recent financial results.

What is Estrella Immunopharma’s dividend yield?

Estrella Immunopharma does not currently have a dividend yield.

Estrella Immunopharma

Estrella Immunopharma Financials at a Glance

ESLA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Estrella Immunopharma

ESLA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Estrella Immunopharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ESLA

What is the current price of Estrella Immunopharma?

What is the 52-week range for Estrella Immunopharma?

How much debt does Estrella Immunopharma have?

How much cash does Estrella Immunopharma have on hand?

What is Estrella Immunopharma’s dividend yield?

Premium Investing Services